Daniele Raggi

11PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Aug 16, 2025
HER2 and urothelial carcinoma: current understanding and future directions.

Daniele Raggi, Emanuele Crupi, Filippo Pederzoli

|May 23, 2025
Management of Testicular Cancer.

Daniele Raggi, Deep Chakrabarti, Walter Cazzaniga

|Mar 04, 2025
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis.

Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi

|Dec 03, 2024
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.

Emanuele Crupi, Tiago Costa de Padua, Laura Marandino

|Sep 06, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.

Chiara Mercinelli, Marco Moschini, Antonio Cigliola

Pageof 2

Frequent Collaborators

6 joint publications

Andrea Necchi

4 joint publications

Emanuele Crupi

4 joint publications

Filippo Pederzoli

4 joint publications

Robert A Huddart